Newborn screening platform for lysosomal storage disorders with FDA clearance and CE mark

SEEKER is a high throughput laboratory solution that quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens. Reduced activity of these enzymes may be indicative of:

Mucopolysaccharidosis Type I (MPS I), Pompe, Gaucher or Fabry disease

Everything your lab needs for LSD screening in one small workstation

SEEKER Features:

  • Flexible
  • Cost-effective
  • Fast results
  • Simple operation

SEEKER Brochure

Powered by digital microfluidics technology, Baebies SEEKER provides newborn screening results in under 3 hours for multiple LSDs from a single DBS punch. SEEKER’s first tier enzymatic assay results can be paired with second tier genetic sequencing to reduce false positives, preventing unnecessary family anxiety.

Contact us today for more information and to discuss your customized lab needs.

Shipping Policy

Orders made at Medpick are initiated and processed for shipment upon receipt of request from the customer. Please note that our Shipping Services (Fee, Transportation, Loss or Damage of any shipment, etc.) are in accordance with the Seller\'s terms of Shipment.

Refund Policy

Please refer to Medpick Return Policy.

Cancellation / Return / Exchange Policy

Please refer to Medpick Return Policy.

Recently view product

SHOPPING FOR A BUSINESS?

 

Sign up for Insider Pricing and get access to attractive discounted prices on commercially rated products as well as dedicated Account Representatives to manage your orders.

LOGIN

REGISTER

SHOPPING FOR A BUSINESS?

Sign up for Insider Pricing and get access to attractive discounted prices on commercially rated products as well as dedicated Account Representatives to manage your orders.

 

LOGIN

REGISTER

Ask for Quote

    Enter your Name*


    Enter your Email Id*

    Mobile Number*

    Enter Message*